One trend in access to medicines may be cause for concern
Catherine Cheney of Devex reports on the results of the 2018 Access to Medicine Index. She highlights the handful of companies carrying out the most urgently needed R&D projects. The article concludes with "the Foundation believes that companies, as well as governments, donors, and other stakeholders, must remain closely aligned with each other, and communicate problems before they create detrimental public health impacts."